Education
About Us
Working with TipRanks
Follow Us
BeOne Medicines (ONC)
NASDAQ:ONC
Earnings Data
Report Date
Apr 01, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.5Last Year’s EPS
0Same Quarter Last Year
Strong Buy
Based on 13 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlights strong financial performance with record revenue growth and a solid cash position. Significant achievements in R&D and FDA breakthrough designation for Sonro are positive. However, there are challenges in competitive markets and delays in some studies. Overall, the highlights outweigh the lowlights, indicating a positive outlook.Company Guidance
Record Revenue Growth
Revenue reached $1.4 billion, representing a 41% year-on-year growth. BRUKINSA global revenues eclipsed $1 billion for the first time in a quarter, growing 51% driven by strong performance across all geographies.
Strong Cash Position
The company ended the quarter with over $4 billion in cash and generated over $350 million of free cash flow during the quarter.
FDA Breakthrough Designation for Sonro
Sonro, the next-generation BCL2 inhibitor, recently received FDA breakthrough designation in relapsed/refractory mantle cell lymphoma.
Positive R&D Developments
Clinical proof-of-concept achieved for multiple early-stage assets in the solid tumor pipeline. 50 abstracts, including 6 orals from the hematology portfolio, accepted for presentation at ASH.
Strong Global Performance
The U.S. revenue grew by 47% year-over-year. Europe contributed $167 million, with 71% year-over-year growth, and rest of world markets grew 133%.
ONC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ONC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $321.39 | $332.36 | +3.41% |
Aug 06, 2025 | $307.23 | $298.52 | -2.84% |
May 07, 2025 | $241.75 | $232.25 | -3.93% |
Mar 27, 2025 | $250.92 | $262.60 | +4.65% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BeOne Medicines (ONC) report earnings?
BeOne Medicines (ONC) is schdueled to report earning on Apr 01, 2026, TBA (Confirmed).
What is BeOne Medicines (ONC) earnings time?
BeOne Medicines (ONC) earnings time is at Apr 01, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ONC EPS forecast?
ONC EPS forecast for the fiscal quarter 2025 (Q4) is 1.5.